Ethylene-vinyl acetate [EVA] infusion bag market: high demand for environmentally friendly materials promotes market development

According to the report, the global ethylene-vinyl acetate (EVA) infusion bag market is valued at approximately US$128 million in 2019, and is expected to grow at a compound annual growth rate of approximately 7% from 2020 to 2030. Increased awareness of parenteral nutrition is expected from 2020 to 2030, the treatment of chronic kidney disease and the increase in high prevalence and morbidity will promote the development of the global ethylene-vinyl acetate (EVA) infusion bag market.
It is expected that during the forecast period, North America will account for an important share of the global ethylene-vinyl acetate (EVA) infusion bag market. The growth of the market in this region can be attributed to the increased demand for biological drugs such as vaccines, proteins, antibodies, plasma, enzymes, biologics and peptides for the treatment of cancer, neurological diseases and chronic kidney disease. During the forecast period, rising prevalence of lifestyle diseases, surge in healthcare spending, and a strong economy may contribute to North America’s dominance of the global ethylene-vinyl acetate (EVA) infusion bag market.
Request report brochure-h​​ttps://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=79648
From 2020 to 2030, the Asia-Pacific market is expected to grow at a high compound annual growth rate of 7.3%. This can be attributed to the expansion of the healthcare industry in countries such as China, Japan, and India. In addition, it is expected that the development and sales growth of biopharmaceuticals in countries such as Japan, India and China will drive the market in this region during the forecast period.
Parenteral nutrition (PN) is a nutrient that is given intravenously. It can combine trace components such as protein, starch, fat, minerals, electrolytes, and vitamins, and is used for patients who cannot eat or eat enough. Completing privileged nutrition admissions in a prescribed manner can help combat complexity and is a key part of patient recovery. Parenteral nutrition is also called total parenteral nutrition (TPN). EVA has a successful and long history in parenteral applications. Currently, EVA bags are used for intravenous delivery of total parenteral nutrition (TPN). In addition, EVA bags are used for parenteral delivery of composite fluids. Generally, ingredients or drugs are used to mix various drugs together. For example, the fluid produced by mixing parenteral nutrition and chemotherapy drugs.
Request to analyze the impact of COVID-19 on the ethylene-vinyl acetate (EVA) infusion bag market-https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=79648
The main purpose of parenteral nutrition is to provide adequate dietary assistance for patients who continue to be sick. The high incidence of malignant tumors, gastrointestinal diseases, ischemic bowel diseases, diabetic complications, and Crohn’s disease are turning interest to parenteral nutrition. According to the World Health Organization (WHO), about 11% of diseases in the world are caused by lack of healthy food. Due to nutritional security and changing ecological conditions, this percentage is expected to rise in the near future. Therefore, interest in parenteral nutrition is expected to remain unchanged. Therefore, during the forecast period, increased awareness of parenteral nutrition therapy may promote the development of the global ethylene-vinyl acetate (EVA) infusion bag market.
In terms of chambers, the global ethylene-vinyl acetate (EVA) infusion bag market is divided into single chamber and multi-chamber. Single-chamber bags are mainly used for common intravenous injections, such as rinsing fluids, drip bags and sterile water. As a result, the utilization rate of single-cavity bags is very high, which in turn is expected to promote the development of this market segment during the forecast period.
Customized research request-https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=79648
According to the capacity, the global ethylene-vinyl acetate (EVA) infusion bag market is divided into 50 to 150 ml, 150 to 500 ml, 500 to 1,500 ml, 1,500 to 3,500 ml and others (4,000 ml, 5,000 ml, etc.). Because of 150 Bags up to 500 ml are used to deliver various types of parenteral nutrition, and the 150 to 500 ml market segment is expected to dominate the global ethylene-vinyl acetate (EVA) infusion bag market during the forecast period.
In terms of end users, the global ethylene-vinyl acetate (EVA) infusion bag market has been divided into hospitals, clinics, and outpatient surgery centers. It is estimated that by 2030, the hospital sector will occupy an important share in the global ethylene-vinyl acetate (EVA) infusion bag market. Due to the extensive use of intravenous infusion, dialysis and minimally invasive endoscopic surgery, the hospital sector dominates the global market due to the convenience facilities and facilities provided by the hospital, preferential reimbursement policies, well-trained staff, and the presence of specialists and surgeons , The patient’s preference for the hospital.
Buy ethylene vinyl acetate (EVA) infusion bag market report at https://www.transparencymarketresearch.com/checkout.php?rep_id=79648<ype=S
The report provides an overview of the leading companies operating in the global ethylene vinyl acetate (EVA) infusion bag market. These include B. Braun Melsungen AG, ICU Medical, Inc., Baxter International, Inc., Fresenius Kabi AG, Technoflex, The Metrix Company, McKesson Medical-Surgical, Inc., AdvaCare Pharma, Valmed and Haemotronic.
Medical Talent Management IT Market: https://www.transparencymarketresearch.com/medical-talent-management-it-market.html
Air-assisted patient transfer system market: https://www.transparencymarketresearch.com/air-assistant-patient-transfer-systems-market.html
Medical payment service market: https://www.transparencymarketresearch.com/healthcare-payer-services-market.html
Transparency Market Research is a next-generation market intelligence provider that provides business leaders, consultants and strategic professionals with fact-based solutions.
Our report is a single point solution for business growth, development and maturity. Our real-time data collection method and ability to track more than 1 million high-growth niche products meet your goals. The detailed and proprietary statistical models used by our analysts provide insights for making the right decisions in the shortest possible time. For organizations that require specific but comprehensive information, we provide customized solutions through ad hoc reports. These requests are delivered through a perfect combination of correct fact-oriented problem solving methods and the use of existing data repositories.
TMR believes that the combination of solutions to customer specific problems and correct research methods is the key to helping companies make correct decisions.
Contact Mr. Rohit Bhisey Transparency Market Research State Tower, 90 State Street, Suite 700, Albany NY-12207 United States of America-Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: https://www. transparencymarketresearch.com /